Clinical Trials Browser

Phase 2/3 × Withdrawn × 1 year × Clear all

NCT07084909 2025-12-10

HARRIER

Phase 2/3 Withdrawn

Carcinoma, Renal Cell, Kidney Neoplasms

NCT01861938 2025-10-02

Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients

Phase 2/3 Withdrawn

Melanoma, Neoplasm Metastasis

NCT06513884 2025-06-22

A Study of HB-202/HB-201 With Pembrolizumab in Patients With HPV16+ Recurrent/Metastatic Oropharyngeal Cancer

Phase 2/3 Withdrawn

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms, Squamous Cell